BASF's Capital Jigsaw: Harbour Buyback, Zhanjiang Ramp-Up, and the 2028 Targets Under Scrutiny

BASF's 2028 EBITDA and cash flow goals hinge on Zhanjiang ramp-up and cost cuts, as the stock falls 2.8% and the Apple lawsuit weighs.

BASF has spent the past two weeks laying out its medium-term case in unusual detail, and the market has responded with a reminder that promises cut both ways. The chemicals group used back-to-back appearances at the Commerzbank and ODDO BHF corporate conference in early September to put hard numbers behind its "Winning Ways" strategy: EBITDA before special items of EUR 10 to 12 billion by 2028, a return on capital employed of roughly 10%, and cumulative free cash flow north of EUR 12 billion across 2025 to 2028. A day later, at the CICC International Corporate Conference, management fleshed out the operational side — structural cost reductions, lower capital expenditure, higher plant utilization, and the ramp-up of the Zhanjiang Verbund site.

Those targets now carry more weight than they did a fortnight ago, because the share price has lost its footing. After closing at EUR 53.37 on Thursday, the stock was trading at EUR 51.86 today, a 2.8% slide in a single session and a 2.9% decline over the week. The retreat has pushed a question to the foreground: does "Winning Ways" pack enough operational substance to win back investor confidence, quite apart from the Apple lawsuit filed roughly a week ago that has weighed on the stock since?

Where the Strategy Actually Stands or Falls

Everything hinges on operating margin paired with capacity utilization. The ROCE figure, the free cash flow, the payout ratio — all of them ultimately depend on whether BASF delivers the structural cost savings it has announced and brings its plants, above all the new Zhanjiang complex, up to speed on schedule. If utilization lags expectations, both the EBITDA target and the cash flow underpinning shareholder returns come under pressure. That is precisely the line dividing the bullish case from the bearish one.

The Bull Case

Should Zhanjiang ramp up as planned and the cost-cutting programs take hold, BASF could genuinely reach the upper end of its EBITDA range at EUR 12 billion. The ongoing buyback — 484,017 shares were repurchased between August 31 and September 4 alone — would then read as a credible signal of capital discipline rather than mere housekeeping of surplus liquidity. Operational advances such as the new acid chlorides and chloroformates plant in Ludwigshafen, or product innovations like the low-emission Lupragen BisDMAPU catalyst, reinforce the impression that the group keeps investing in technology despite cost pressure. On that path, the stock could retrace its way toward the 52-week high of EUR 55.05, a level last touched in April.

The Bear Risk

The opposite scenario deserves equal attention. If the Zhanjiang ramp-up stalls or global demand for chemical products stays weaker than assumed, the ambitious 2028 goals risk turning into dead letters. The pledge to distribute at least EUR 12 billion between 2025 and 2028 presupposes dependable cash flow; should that falter, BASF would have to choose between returning capital to shareholders and preserving room to invest. Legal uncertainty from the Apple suit compounds the problem: the claim has been filed but is far from decided, and a dispute that could run for years absorbs resources without adding capital in the near term. The shares already sit 5.8% below their 52-week high — a sign the market is not ignoring the risks.

A Portfolio Being Reshaped From Several Directions

Running alongside the strategy update is a steady stream of portfolio moves designed to free up cash. Harbour Energy is buying back its own shares from its major shareholder BASF, in a transaction that could reach up to USD 200 million. The repurchase trims BASF's stake in the British oil and gas company while putting liquid funds into group coffers — another building block in a portfolio overhaul that has lately been defined by much larger deals.

The timing is telling. BASF confirmed on July 29, 2026 a buyback program of up to EUR 1.0 billion, which began in August and is scheduled to run through the end of April 2027. That program forms part of the EUR 4 billion total announced in September 2024, which the company intends to return to shareholders by the end of 2028.

Earlier, at the end of June, BASF transferred its coatings division to Carlyle, generating a pre-tax cash inflow of roughly EUR 5.8 billion against an enterprise value of EUR 7.7 billion. BASF retains a 40% stake in the new entity, now operating under the name Surventis. For investors, the Harbour Energy repurchase fits a pattern in which BASF systematically monetizes peripheral holdings and businesses to shore up the balance sheet and fund distributions. Individual transactions of this size do not move billions, but they contribute to the broader realignment of the group's capital allocation.

Operations Provide the Tailwind

These capital measures land in a phase where the underlying business is running better than expected. In the second quarter, BASF reported EBITDA before special items of EUR 2.4 billion, comfortably beating average analyst forecasts. The group subsequently raised its full-year guidance: EBITDA before special items is now projected at EUR 6.9 to 7.7 billion, up from a prior range of EUR 6.2 to 7.0 billion. The free cash flow forecast was left unchanged at EUR 1.5 to 2.3 billion.

Market sentiment reflects the improvement. BASF shares closed Thursday at EUR 53.37, up 1.5% on the day, bringing the year-to-date gain to 20% — a sign that investors are rewarding the combination of operational recovery and active capital returns.

What to Watch

As long as BASF keeps the operational milestones of "Winning Ways" — cost reductions, utilization, the Zhanjiang ramp-up — on schedule, the upside case remains intact, supported by continuing buybacks and the proximity of the 200-day moving average at EUR 49.11 as a floor. If utilization tips over or the Chinese site falls noticeably behind, the market is likely to reassess the distribution pledges and widen the gap to the annual high.

The next concrete test will be reporting on progress at Zhanjiang, supplemented by further interim updates on the buyback program, which runs until April 2027. Whether BASF can maintain its pace on portfolio streamlining and payouts in the months ahead will be decisive — smaller deals like the Harbour Energy repurchase may not grab headlines, but they underscore the consistency with which the group is currently recalibrating its capital structure. Until the operational proof arrives, the stock remains a case of weighing strategic ambition against the burden of demonstration.